IL-10: a potential therapy for allergic inflammation?
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 18 (6), 277-280
- https://doi.org/10.1016/s0167-5699(97)80023-0
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin‐4, ‐10 and ‐13Immunology, 1996
- Interleukin‐10 inhibits cytokine generation from mast cellsEuropean Journal of Immunology, 1996
- Cytokine generation by eosinophilsJournal of Allergy and Clinical Immunology, 1994
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.The Journal of Experimental Medicine, 1994
- Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.The Journal of Experimental Medicine, 1994
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Mast cells as a source of multifunctional cytokinesImmunology Today, 1990
- Granulocyte-macrophage colony-stimulating factor: More than a hemopoietinClinical Immunology and Immunopathology, 1990